Product
AC-OLE-02
1 clinical trial
1 indication
Indication
Alzheimer's diseaseClinical trial
A Phase 1, Three-part, Part-randomised, Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Different Formulations of Tricaprilin, to Include Single-dose, Food Effect, and Titration Tolerability, in Healthy ParticipantsStatus: Terminated, Estimated PCD: 2022-03-18